NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

Consumer Health: Stroke Awareness

Consumer Health: Stroke Awareness

NeurologyLive® Staff
May 12th 2021

Understanding the signs and symptoms stroke during National Stroke Awareness Month.

This Week on NeurologyLive — May 10, 2021

This Week on NeurologyLive — May 10, 2021

NeurologyLive® Staff
May 10th 2021

Here's what is coming soon to NeurologyLive.

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

NeurologyLive® Staff
May 8th 2021

Neurology News Network for the week ending May 8, 2021.

NeurologyLive Friday 5 — May 7, 2021

NeurologyLive Friday 5 — May 7, 2021

NeurologyLive® Staff
May 7th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 7, 2021.

Unique Neurologic Symptoms Lead to Surprising Cancer Diagnosis

Unique Neurologic Symptoms Lead to Surprising Cancer Diagnosis

NeurologyLive® Staff
May 5th 2021

Lightheadness, loss of balance, vision changes, and abnormal eye movements led to the discovery of cancer in one specific patient.

This Week on NeurologyLive — May 3, 2021

This Week on NeurologyLive — May 3, 2021

NeurologyLive® Staff
May 3rd 2021

Here's what is coming soon to NeurologyLive.

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

NeurologyLive® Staff
May 1st 2021

Neurology News Network for the week ending May 1, 2021.

NeurologyLive Friday 5 — April 30, 2021

NeurologyLive Friday 5 — April 30, 2021

NeurologyLive® Staff
April 30th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 30, 2021.

This Week on NeurologyLive — April 26, 2021

This Week on NeurologyLive — April 26, 2021

NeurologyLive® Staff
April 26th 2021

Here's what is coming soon to NeurologyLive.

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

NeurologyLive® Staff
April 24th 2021

Neurology News Network for the week ending April 24, 2021.

NeurologyLive Friday 5 — April 23, 2021

NeurologyLive Friday 5 — April 23, 2021

NeurologyLive® Staff
April 23rd 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 23, 2021.

This Week on NeurologyLive — April 19, 2021

This Week on NeurologyLive — April 19, 2021

NeurologyLive® Staff
April 19th 2021

Here's what is coming soon to NeurologyLive.

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

NeurologyLive® Staff
April 17th 2021

Neurology News Network for the week ending April 17, 2021.

NeurologyLive Friday 5 — April 16, 2021

NeurologyLive Friday 5 — April 16, 2021

NeurologyLive® Staff
April 16th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 16, 2021.

This Week on NeurologyLive — April 12, 2021

This Week on NeurologyLive — April 12, 2021

NeurologyLive® Staff
April 12th 2021

Here's what is coming soon to NeurologyLive.

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

NeurologyLive® Staff
April 10th 2021

Neurology News Network for the week ending April 10, 2021.

NeurologyLive Friday 5 — April 9, 2021

NeurologyLive Friday 5 — April 9, 2021

NeurologyLive® Staff
April 9th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 9, 2021.

This Week on NeurologyLive — April 5, 2021

This Week on NeurologyLive — April 5, 2021

NeurologyLive® Staff
April 5th 2021

Here's what is coming soon to NeurologyLive.

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

NeurologyLive® Staff
April 3rd 2021

Neurology News Network for the week ending April 3, 2021.

NeurologyLive Friday 5 — April 2, 2021

NeurologyLive Friday 5 — April 2, 2021

NeurologyLive® Staff
April 2nd 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 2, 2021.

This Week on NeurologyLive — March 29, 2021

This Week on NeurologyLive — March 29, 2021

NeurologyLive® Staff
March 29th 2021

Here's what is coming soon to NeurologyLive.

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

NeurologyLive® Staff
March 27th 2021

Neurology News Network for the week ending March 27, 2021.

NeurologyLive Friday 5 — March 26, 2021

NeurologyLive Friday 5 — March 26, 2021

NeurologyLive® Staff
March 26th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 26, 2021.

Outcomes and Risk Factors Associated with COVID-19 and Multiple Sclerosis Published

Outcomes and Risk Factors Associated with COVID-19 and Multiple Sclerosis Published

NeurologyLive® Staff
March 24th 2021

Increased disability was independently associated with worse clinical severity including death from COVID-19.

This Week on NeurologyLive — March 22, 2021

This Week on NeurologyLive — March 22, 2021

NeurologyLive® Staff
March 22nd 2021

Here's what is coming soon to NeurologyLive.

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

NeurologyLive® Staff
March 20th 2021

Neurology News Network for the week ending March 20, 2021.

NeurologyLive Friday 5 — March 19, 2021

NeurologyLive Friday 5 — March 19, 2021

NeurologyLive® Staff
March 19th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 19, 2021.

This Week on NeurologyLive — March 15, 2021

This Week on NeurologyLive — March 15, 2021

NeurologyLive® Staff
March 15th 2021

Here's what is coming soon to NeurologyLive.

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

NeurologyLive® Staff
March 13th 2021

Neurology News Network for the week ending March 13, 2021.

NeurologyLive Friday 5 — March 12, 2021

NeurologyLive Friday 5 — March 12, 2021

NeurologyLive® Staff
March 12th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 12, 2021.

<1
...
222324252627282930
...
36>

Latest Updated Articles

Jannis Müller, MD, MSc (Credit: LinkedIn)
Published: May 14th 2025 | Updated: May 16th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)
Published: May 12th 2025 | Updated: May 13th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
Published: February 15th 2025 | Updated: February 18th 2025
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
© 2025 MJH Life Sciences

All rights reserved.